Gene · 862
Papers4,591
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
461 to 480 of 4,591
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Comprehensive molecular understanding of pediatric acute myeloid leukemia. | Int J Hematol | 2023 | 36653696 | PubTator, text mining | PubMed |
| Thioparib inhibits homologous recombination repair, activates the type I IFN response, and overcomes olaparib resistance. | EMBO Mol Med | 2023 | 36652375 | PubTator, text mining | PubMed |
| Human SMARCA5 is continuously required to maintain nucleosome spacing. | Mol Cell | 2023 | 36630954 | PubTator, text mining | PubMed |
| DNA fragility at the KMT2A/MLL locus: insights from old and new technologies. | Open Biol | 2023 | 36629017 | PubTator, text mining | PubMed |
| Structural basis for transcription factor ZBTB7A recognition of DNA and effects of ZBTB7A somatic mutations that occur in human acute myeloid leukemia. | J Biol Chem | 2023 | 36626981 | PubTator, text mining | PubMed |
A phase II study of chidamide, cytarabine, aclarubicin, granulocyte colony-stimulating factor, and donor lymphocyte infusion for relapsed acute myeloid leukemia and myelodysplastic syndrome after allogeneic hematopoietic stem cell transplantation. | Med Oncol | 2023 | 36625951 | PubTator, text mining | PubMed |
| Mechanisms associated with t(7;12) acute myeloid leukaemia: from genetics to potential treatment targets. | Biosci Rep | 2023 | 36622782 | PubTator, text mining | PubMed |
DNA hypermethylation-induced miR-182 silence targets BCL2 and HOXA9 to facilitate the self-renewal of leukemia stem cell, accelerate acute myeloid leukemia progression, and determine the sensitivity of BCL2 inhibitor venetoclax. | Theranostics | 2023 | 36593968 | PubTator, text mining | PubMed |
| Layered immunity and layered leukemogenicity: Developmentally restricted mechanisms of pediatric leukemia initiation. | Immunol Rev | 2023 | 36588481 | PubTator, text mining | PubMed |
| Human Proteome Microarray identifies autoantibodies to tumor-associated antigens as serological biomarkers for the diagnosis of hepatocellular carcinoma. | Mol Oncol | 2023 | 36587394 | PubTator, text mining | PubMed |
| An inflammatory state remodels the immune microenvironment and improves risk stratification in acute myeloid leukemia. | Nat Cancer | 2023 | 36581735 | PubTator, text mining | PubMed |
| Recent advances toward the development of Hsp90 C-terminal inhibitors. | Bioorg Med Chem Lett | 2023 | 36549397 | PubTator, text mining | PubMed |
| The First Case of Acute Myeloid Leukemia With a Novel Five-way Variant Translocation of RUNX1-RUNX1T1. | Ann Lab Med | 2023 | 36544347 | PubTator, text mining | PubMed |
| Molecular Subtypes of Head and Neck Cancer in Patients of African Ancestry. | Clin Cancer Res | 2023 | 36508165 | PubTator, text mining | PubMed |
| A systematic review on extensively drug-resistant tuberculosis from 2009 to 2020: special emphases on treatment outcomes. | Rev Esp Quimioter | 2023 | 36503203 | PubTator, text mining | PubMed |
| Mutant NPM1 Hijacks Transcriptional Hubs to Maintain Pathogenic Gene Programs in Acute Myeloid Leukemia. | Cancer Discov | 2023 | 36455589 | PubTator, text mining | PubMed |
| IMPDH inhibition activates TLR-VCAM1 pathway and suppresses the development of MLL-fusion leukemia. | EMBO Mol Med | 2023 | 36453131 | PubTator, text mining | PubMed |
| Functional analysis of structural variants in single cells using Strand-seq. | Nat Biotechnol | 2023 | 36424487 | PubTator, text mining | PubMed |
| Optical genome mapping in acute myeloid leukemia: a multicenter evaluation. | Blood Adv | 2023 | 36417763 | PubTator, text mining | PubMed |
| A Review of Radiation-Induced Alterations of Multi-Omic Profiles, Radiation Injury Biomarkers, and Countermeasures. | Radiat Res | 2023 | 36368026 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/862/papers?page=24